CSL - Sales Revenues

Stock Price
146.10
Daily Change
0.99 0.68%
Monthly
-19.85%
Yearly
-43.87%
Q1 Forecast
150.05

CSL reported $3.54B in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 190K 2.03M Sep/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
CSL USD 3.54B 4.68B Jun/2025
Curis USD 2.55M 460K Jun/2024
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Minerva Neurosciences USD 0 0 Sep/2024
Sangamo BioSciences USD 356K 125K Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024